INS and type 2 diabetes mellitus: In 240 elderly patients with T2DM affected by mild cognitive impairment (MCI), 2 years treatment group of DPP-4i significantly improve cognitive functions measured by mini-mental state examination (MMSE), compared to the sulfonylurea which increases endogenous release of insulin from pancreatic β cells group (Rizzo et al., 2014).